Dermatitis, Atopic: all 1,443 studies

Page 15 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• Immune Response to Varicella Vaccination in Children With Atopic DermatitisCompletedNCT00406081
• LEO19123 Cream in the Treatment of Atopic DermatitisCompletedNCT00392067Phase 2
• Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)WithdrawnNCT00389103Phase 1
• Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic DermatitisCompletedNCT00379678
• The Effects of Probiotics in Atopic DermatitisWithdrawnNCT00378300Not applicable
• Open-Label,Singel Center Study of Alefacept in Patients With Atopic DermatitisCompletedNCT00376129Phase 2
• Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic DermatitisWithdrawnNCT00368719Phase 4
• Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic DermatitisCompletedNCT00367393Phase 4
• Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic DermatitisCompletedNCT00356642Phase 1
• Topical GW842470X In Adults Patients With Moderate Atopic DermatitisCompletedNCT00354510Phase 2
• Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic DermatitisCompletedNCT00351052Phase 3
• Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal PeriodCompletedNCT00325273Phase 3
• Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic DermatitisCompletedNCT00310492Phase 3
• Histamine Pharmacogenetics in Children With Atopic DermatitisCompletedNCT00277433
• Immunopharmacological Effects of Rituximab in Atopic DermatitisCompletedNCT00267826Not applicable
• Study Of Atopic Dermatitis In PediatricsCompletedNCT00257569Phase 3
• Short Term Growth in Children With Atopic DermatitisCompletedNCT00236106Phase 4
• Verification Study of Ciclosporin for Atopic DermatitisCompletedNCT00232076Phase 3
• Long-term Study of Ciclosporin for Atopic DermatitisCompletedNCT00232063Phase 3
• Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic DermatitisCompletedNCT00232011Phase 3
• Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic DermatitisCompletedNCT00231998Phase 3
• Efalizumab for Moderate to Severe Atopic DermatitisCompletedNCT00226057Phase 1
• Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic DermatitisCompletedNCT00224432Not applicable
• Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic DisordersCompletedNCT00189917Phase 1
• Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic DermatitisCompletedNCT00185510Phase 4
• Elidel-Study: Elidel in Patients With Atopic DermatitisCompletedNCT00180141Phase 4
• Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant PatientsTerminatedNCT00176956Phase 3
• Common Allergens in Skin Tests for Adult Atopic DermatitisStatus unknownNCT00173498
• Impact in Off-spring of Mothers After Perinatal Daily Intake of a ProbioticCompletedNCT00159523Not applicable
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic DermatitisCompletedNCT00150059Phase 4
• Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic DermatitisCompletedNCT00148746Not applicable
• Efalizumab for EczemaCompletedNCT00146003Phase 2
• Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric SubjectsCompletedNCT00139581Phase 4
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic DermatitisCompletedNCT00130364Phase 4
• Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin ConditionsTerminatedNCT00129415Phase 1/2
• Topical NF-kappaB Decoy in the Treatment of Atopic DermatitisCompletedNCT00125333Phase 1/2
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic DermatitisCompletedNCT00121381Phase 4
• Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsCompletedNCT00121316Phase 4
• Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic DermatitisCompletedNCT00117377Phase 4
• A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisCompletedNCT00106496Phase 4
• Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic DermatitisCompletedNCT00098150
• Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)CompletedNCT00076375Phase 2
• Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy IndividualsCompletedNCT00001760

← Dermatitis, Atopic overview